• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬皮病中的人类白细胞抗原、自身抗体及临床亚组

HLA antigens, autoantibodies and clinical subsets in scleroderma.

作者信息

Black C M, Welsh K I, Maddison P J, Jayson M I, Bernstein R M

出版信息

Br J Rheumatol. 1984 Nov;23(4):267-71. doi: 10.1093/rheumatology/23.4.267.

DOI:10.1093/rheumatology/23.4.267
PMID:6593111
Abstract

The HLA antigens were determined in 54 Caucasoid patients with scleroderma (ARA criteria). All were assessed for extent of skin and organ involvement, anticentromere (ACA), and scleroderma 70 (Scl 70) antibodies. The antigens DR1, DR3 and DR5 were raised in the patient group, and DR2 was lowered. Of these only the increase in DR5 was significant (chi 2 = 5.2; p = 0.02). The increased frequency of DR3 was attributable to a rise in the A1, B8, DR3 haplotype (chi 2 = 3.9; p = 0.05). Patients with non-diffuse disease showed a significant increase in the DR1 and DR5 antigens (chi 2 = 3.7, p = 0.05; chi 2 = 8.0, p = 0.01). No association was found between the HLA antigens and specific organ involvement. Anticentromere antibodies were present in 15 of the HLA-DR typed patients. Thirteen of these 15 patients were either DR1 or DR5. No relationship was found between the frequencies of HLA antigens and anti-Scl 70 antibodies.

摘要

对54例符合美国风湿病学会(ARA)标准的白种人硬皮病患者进行了HLA抗原检测。所有患者均评估了皮肤和器官受累程度、抗着丝点抗体(ACA)和硬皮病70抗体(Scl 70)。患者组中DR1、DR3和DR5抗原升高,DR2抗原降低。其中只有DR5的升高具有统计学意义(χ2 = 5.2;p = 0.02)。DR3频率的增加归因于A1、B8、DR3单倍型的升高(χ2 = 3.9;p = 0.05)。非弥漫性疾病患者的DR1和DR5抗原显著增加(χ2 = 3.7,p = 0.05;χ2 = 8.0,p = 0.01)。未发现HLA抗原与特定器官受累之间存在关联。在进行了HLA - DR分型的患者中,15例存在抗着丝点抗体。这15例患者中有13例为DR1或DR5。未发现HLA抗原频率与抗Scl 70抗体之间存在关系。

相似文献

1
HLA antigens, autoantibodies and clinical subsets in scleroderma.硬皮病中的人类白细胞抗原、自身抗体及临床亚组
Br J Rheumatol. 1984 Nov;23(4):267-71. doi: 10.1093/rheumatology/23.4.267.
2
Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).进行性系统性硬化症(PSS;硬皮病)中的组织相容性抗原
J Clin Immunol. 1982 Oct;2(4):314-8. doi: 10.1007/BF00915073.
3
HLA-DR antigens in progressive systemic sclerosis (scleroderma).进行性系统性硬化症(硬皮病)中的人类白细胞抗原DR抗原
J Rheumatol. 1983 Feb;10(1):128-31.
4
Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.日本弥漫性硬皮病患者和局限性硬皮病患者之间的遗传和免疫学差异。
J Rheumatol. 1994 Jan;21(1):111-4.
5
Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Clin Exp Rheumatol. 1987 Oct-Dec;5(4):317-21.
6
Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma).HLA抗原与抗Scl - 70抗体及系统性硬化症(硬皮病)临床表现的关联。
Br J Rheumatol. 1994 Apr;33(4):323-6. doi: 10.1093/rheumatology/33.4.323.
7
Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.进行性系统性硬化症与多个 HLA - B 和 HLA - DR 等位基因的关联。
Arch Dermatol. 1987 Sep;123(9):1188-91.
8
Immunogenetic associations of scleroderma-related antinuclear antibodies.
Arthritis Rheum. 1990 May;33(5):657-65. doi: 10.1002/art.1780330508.
9
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.系统性硬化症患者血清自身抗体的临床相关性及预后
Arthritis Rheum. 1988 Feb;31(2):196-203. doi: 10.1002/art.1780310207.
10
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).HLA-DQB1第一结构域第26位极性氨基酸与系统性硬化症(硬皮病)中抗着丝点自身抗体反应的关联。
J Clin Invest. 1992 Apr;89(4):1208-13. doi: 10.1172/JCI115704.

引用本文的文献

1
Systemic sclerosis: To subset or not to subset, that is the question.系统性硬化症:是否进行亚组分析,这是个问题。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. Epub 2020 Jul 6.
2
Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.采用全基因组表达谱分析捕捉系统性硬化症的异质性。
Expert Rev Clin Immunol. 2011 Jul;7(4):463-73. doi: 10.1586/eci.11.41.
3
Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.
硬皮病(系统性硬化症)患者及其血亲与配偶体内的抗核抗体
Ann Rheum Dis. 1993 May;52(5):365-8. doi: 10.1136/ard.52.5.365.
4
Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.系统性硬化症患者及其亲属中的抗着丝点抗体(ACA):一项血清学和HLA研究。
Clin Exp Immunol. 1994 May;96(2):267-74. doi: 10.1111/j.1365-2249.1994.tb06552.x.
5
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).HLA - DR和DQ基因控制系统性硬化症(硬皮病)中针对DNA拓扑异构酶I的自身免疫反应。
J Clin Invest. 1993 Sep;92(3):1296-301. doi: 10.1172/JCI116703.
6
Regressive systemic sclerosis.退行性系统性硬化症
Ann Rheum Dis. 1986 May;45(5):384-8. doi: 10.1136/ard.45.5.384.
7
Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes.硬皮病(系统性硬化症)的家族研究表明,培养的淋巴细胞中存在与HLA相关的染色体断裂率增加的情况。
Hum Genet. 1988 Dec;81(1):64-70. doi: 10.1007/BF00283732.
8
Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.系统性硬化症患者亲属及配偶中的抗核抗体
Ann Rheum Dis. 1986 Oct;45(10):793-9. doi: 10.1136/ard.45.10.793.
9
Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.系统性硬化症中的抗动粒抗体和抗拓扑异构酶I抗体:使用免疫印迹重组抗原、免疫荧光和双向免疫扩散的比较研究
Arch Dermatol Res. 1990;282(2):76-83. doi: 10.1007/BF00493462.
10
Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypes.与类风湿性关节炎和轻度炎症性关节炎相关的基因。I. 主要组织相容性复合体I类、II类和III类同种异型。
Ann Rheum Dis. 1990 Apr;49(4):219-24. doi: 10.1136/ard.49.4.219.